newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Provides SEC Reporting Update

TORRANCE, Calif., Aug. 10, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC:EMMA), a leader in sickle cell disease treatment, announced today that it has restated its financial statements for the fiscal year ended December 31, 2020,